Found: 7
Select item for more details and to access through your institution.
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30950-z
- By:
- Publication type:
- Article
Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA).
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092191
- By:
- Publication type:
- Article
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden.
- Published in:
- 2019
- By:
- Publication type:
- Journal Article
ALK-negative anaplastic large cell lymphoma arising in the thrombus of an aortic prosthesis preceeded by clonally related lymphomatoid papulosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinicohistopathological Characteristics of Malignant Melanoma in the Gall Bladder: A Case Report and Review of the Literature.
- Published in:
- Case Reports in Pathology, 2018, p. 1, doi. 10.1155/2018/6471923
- By:
- Publication type:
- Article
Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 2, p. 255, doi. 10.1111/bjh.14049
- By:
- Publication type:
- Article